<DOC>
	<DOCNO>NCT02403050</DOCNO>
	<brief_summary>Currently , patient suitable fitness non-metastatic esophageal cancer treat surgery , radiotherapy chemoradiotherapy . If treat radio chemoradiotherapy , Computerised tomography ( CT ) scan perform dataset use planning radiotherapy . Information endoscopic ultrasound ( EUS ) , perform routine staging , use help localize tumor , tumor esophagus poorly visualise CT . This information subjective dependant clinician performing procedure . The tumor describe relation common anatomical landmark . Interpretion information lead over-compensation attempt cover tumor radiation field , avoid `` miss '' . It think use fiducial marker call Visicoils place adjacent tumor 's top bottom extent time EUS , lead good definition tumor planning process hence , improvement local tumor control , reduction radiotherapy dose normal tissue .</brief_summary>
	<brief_title>Feasibility Study Fiducial Markers Oesophageal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<criteria>esophageal adenocarcinoma squamous carcinoma , undifferentiated carcinoma . No previous radiotherapy chemotherapy . Fit radical treatment cancer reasonable lung function , Fev1 &gt; 40 % , EUS plan . ECOG Performance Status 01 : 0 Fully active , able carry predisease performance without restriction 1 Restricted physically strenuous activity Pregnancy breast feeding . Allergy ciprofloxacin antibiotic</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Neoplasm Staging</keyword>
	<keyword>Radiotherapy</keyword>
	<keyword>Fiducial Markers</keyword>
</DOC>